Detalhe da pesquisa
1.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748513
2.
Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome.
J Clin Apher
; 31(5): 443-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26411360
3.
Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
Am J Hematol
; 90(7): 634-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809173
4.
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.
Br J Haematol
; 167(1): 121-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992281